Literature DB >> 17259794

Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome.

F Orio1, E Ferrarini, T Cascella, A Dimida, S Palomba, E Gianetti, A Colao, P Agretti, P Vitti, G Lombardi, A Pinchera, M Tonacchera.   

Abstract

This study was designed to assess the relationship between mutations in the FSH receptor (FSHr) gene and polycystic ovary syndrome (PCOS) in Italian women. The study population included 50 patients with PCOS and 50 age- and body mass index (BMI)-matched controls. A complete anthropometrical, hormonal and pelvic ultrasonographic evaluation was performed in all subjects. Genomic DNA was extracted from peripheral lymphocytes and then each exon of the FSHr gene was amplified by PCR. The mutation identified was cloned and the functional properties were studied after transient expression in COS-7 cells. Direct sequencing of exons 1-10 of the FSHr gene revealed the presence of a heterozygous AAT/ATT mutation affecting the isoleucine residue at position 411, which was replaced by an asparagine, in the second transmembrane segment (I411N). This mutation was only found in one woman with PCOS and not in her parents. This mutation was not present in 50 age and BMI controls and in another 150 women not affected by PCOS. The functional study after transient expression in COS-7 cells revealed that this I411N had similar functional characteristics with respect to the wild type FSHr (wtFSHr). Genetic analyses of polymorphisms in the human FSHr gene were also performed. All 50 women with PCOS harbored the A307T polymorphic variant, 56% harbored N680S, 30% S680S and 14% N680N polymorphisms. In conclusion, the present study demonstrates that mutations of the FSHr gene are rare in Italian women. The only mutation that we found does not appear to have any pathophysiological significance in PCOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17259794     DOI: 10.1007/BF03349210

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.

Authors:  M Perez Mayorga; J Gromoll; H M Behre; C Gassner; E Nieschlag; M Simoni
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure.

Authors:  Elaine Doherty; Pirjo Pakarinen; Aila Tiitinen; Anna Kiilavuori; Ilpo Huhtaniemi; Susan Forrest; Kristiina Aittomäki
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

3.  Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.

Authors:  A De Leener; L Montanelli; J Van Durme; Heedong Chae; G Smits; G Vassart; S Costagliola
Journal:  J Clin Endocrinol Metab       Date:  2005-11-08       Impact factor: 5.958

Review 4.  Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation.

Authors:  J S Richards
Journal:  Physiol Rev       Date:  1980-01       Impact factor: 37.312

Review 5.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

6.  A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics.

Authors:  Linda A Allen; John C Achermann; Pirjo Pakarinen; Thomas J Kotlar; Ilpo T Huhtaniemi; J Larry Jameson; Tim D Cheetham; Stephen G Ball
Journal:  Hum Reprod       Date:  2003-02       Impact factor: 6.918

7.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.

Authors:  K Aittomäki; J L Lucena; P Pakarinen; P Sistonen; J Tapanainen; J Gromoll; R Kaskikari; E M Sankila; H Lehväslaiho; A R Engel; E Nieschlag; I Huhtaniemi; A de la Chapelle
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

Review 8.  Observations in favor of normal early follicle development and disturbed dominant follicle selection in polycystic ovary syndrome.

Authors:  B C Fauser
Journal:  Gynecol Endocrinol       Date:  1994-06       Impact factor: 2.260

9.  Insulin resistance in nonobese patients with polycystic ovarian disease.

Authors:  R J Chang; R M Nakamura; H L Judd; S A Kaplan
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

10.  Genetic and functional analyses of polymorphisms in the human FSH receptor gene.

Authors:  Satoko Sudo; Masataka Kudo; Shin-ichiro Wada; Osamu Sato; Aaron J W Hsueh; Seiichiro Fujimoto
Journal:  Mol Hum Reprod       Date:  2002-10       Impact factor: 4.025

View more
  4 in total

Review 1.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

2.  FSH receptor gene p. Thr307Ala and p. Asn680Ser polymorphisms are associated with the risk of polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi; Min A Hong; Soo Jin Chae; Kyuri Hwang; Sang Ho Yoon; Seung Yup Ku; Chang Suk Suh; Seok Hyun Kim
Journal:  J Assist Reprod Genet       Date:  2017-05-25       Impact factor: 3.412

3.  Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.

Authors:  Tugba Unsal; Ece Konac; Ediz Yesilkaya; Akin Yilmaz; Aysun Bideci; Hacer Ilke Onen; Peyami Cinaz; Adnan Menevse
Journal:  J Assist Reprod Genet       Date:  2009-04-22       Impact factor: 3.412

4.  Follicle-stimulating hormone receptor gene polymorphism in chronic anovulatory women, with or without polycystic ovary syndrome: a cross-sectional study.

Authors:  Wanakan Singhasena; Tawiwan Pantasri; Waraporn Piromlertamorn; Sudarat Samchimchom; Teraporn Vutyavanich
Journal:  Reprod Biol Endocrinol       Date:  2014-09-02       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.